About (7S,9E,11S,12R,13R,14R,15R,19S,20S,21E,23Z,35R)-2,34-dihydroxy-13-[hydroxy(morpholin-4-yl)methoxy]-11-methoxy-3,7,12,14,17,17,20,24,35-nonamethyl-1'-(2-methylpropyl)spiro[8,16,18,36-tetraoxa-26,29,31-triazahexacyclo[25.6.1.14,7.115,19.05,33.028,32]hexatriaconta-1(34),2,4,9,21,23,26,28,32-nonaene-30,4'-piperidine]-6,25-dione
(7S,9E,11S,12R,13R,14R,15R,19S,20S,21E,23Z,35R)-2,34-dihydroxy-13-[hydroxy(morpholin-4-yl)methoxy]-11-methoxy-3,7,12,14,17,17,20,24,35-nonamethyl-1'-(2-methylpropyl)spiro[8,16,18,36-tetraoxa-26,29,31-triazahexacyclo[25.6.1.14,7.115,19.05,33.028,32]hexatriaconta-1(34),2,4,9,21,23,26,28,32-nonaene-30,4'-piperidine]-6,25-dione (PubChem CID 177145158) has the molecular formula C52H73N5O12
and a molecular weight of 960.18 g/mol. Its IUPAC name is (7S,9E,11S,12R,13R,14R,15R,19S,20S,21E,23Z,35R)-2,34-dihydroxy-13-[hydroxy(morpholin-4-yl)methoxy]-11-methoxy-3,7,12,14,17,17,20,24,35-nonamethyl-1'-(2-methylpropyl)spiro[8,16,18,36-tetraoxa-26,29,31-triazahexacyclo[25.6.1.14,7.115,19.05,33.028,32]hexatriaconta-1(34),2,4,9,21,23,26,28,32-nonaene-30,4'-piperidine]-6,25-dione.
Frequently Asked Questions
What is the IUPAC name of (7S,9E,11S,12R,13R,14R,15R,19S,20S,21E,23Z,35R)-2,34-dihydroxy-13-[hydroxy(morpholin-4-yl)methoxy]-11-methoxy-3,7,12,14,17,17,20,24,35-nonamethyl-1'-(2-methylpropyl)spiro[8,16,18,36-tetraoxa-26,29,31-triazahexacyclo[25.6.1.14,7.115,19.05,33.028,32]hexatriaconta-1(34),2,4,9,21,23,26,28,32-nonaene-30,4'-piperidine]-6,25-dione?
The IUPAC name of (7S,9E,11S,12R,13R,14R,15R,19S,20S,21E,23Z,35R)-2,34-dihydroxy-13-[hydroxy(morpholin-4-yl)methoxy]-11-methoxy-3,7,12,14,17,17,20,24,35-nonamethyl-1'-(2-methylpropyl)spiro[8,16,18,36-tetraoxa-26,29,31-triazahexacyclo[25.6.1.14,7.115,19.05,33.028,32]hexatriaconta-1(34),2,4,9,21,23,26,28,32-nonaene-30,4'-piperidine]-6,25-dione (CID 177145158) is (7S,9E,11S,12R,13R,14R,15R,19S,20S,21E,23Z,35R)-2,34-dihydroxy-13-[hydroxy(morpholin-4-yl)methoxy]-11-methoxy-3,7,12,14,17,17,20,24,35-nonamethyl-1'-(2-methylpropyl)spiro[8,16,18,36-tetraoxa-26,29,31-triazahexacyclo[25.6.1.14,7.115,19.05,33.028,32]hexatriaconta-1(34),2,4,9,21,23,26,28,32-nonaene-30,4'-piperidine]-6,25-dione.
What is the SMILES notation for (7S,9E,11S,12R,13R,14R,15R,19S,20S,21E,23Z,35R)-2,34-dihydroxy-13-[hydroxy(morpholin-4-yl)methoxy]-11-methoxy-3,7,12,14,17,17,20,24,35-nonamethyl-1'-(2-methylpropyl)spiro[8,16,18,36-tetraoxa-26,29,31-triazahexacyclo[25.6.1.14,7.115,19.05,33.028,32]hexatriaconta-1(34),2,4,9,21,23,26,28,32-nonaene-30,4'-piperidine]-6,25-dione?
The canonical SMILES for (7S,9E,11S,12R,13R,14R,15R,19S,20S,21E,23Z,35R)-2,34-dihydroxy-13-[hydroxy(morpholin-4-yl)methoxy]-11-methoxy-3,7,12,14,17,17,20,24,35-nonamethyl-1'-(2-methylpropyl)spiro[8,16,18,36-tetraoxa-26,29,31-triazahexacyclo[25.6.1.14,7.115,19.05,33.028,32]hexatriaconta-1(34),2,4,9,21,23,26,28,32-nonaene-30,4'-piperidine]-6,25-dione is CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)/c(c5c(c4c3C2=O)NC2(CCN(CC(C)C)CC2)N=5)=N/C(=O)/C(C)=C\C=C\[C@H](C)[C@@H]2OC(C)(C)O[C@@H]([C@@H](C)[C@H](OC(O)N3CCOCC3)[C@@H]1C)[C@@H]2C.
What is the InChIKey of (7S,9E,11S,12R,13R,14R,15R,19S,20S,21E,23Z,35R)-2,34-dihydroxy-13-[hydroxy(morpholin-4-yl)methoxy]-11-methoxy-3,7,12,14,17,17,20,24,35-nonamethyl-1'-(2-methylpropyl)spiro[8,16,18,36-tetraoxa-26,29,31-triazahexacyclo[25.6.1.14,7.115,19.05,33.028,32]hexatriaconta-1(34),2,4,9,21,23,26,28,32-nonaene-30,4'-piperidine]-6,25-dione?
The InChIKey is OJQVSURIDRAJMB-NJGQISAUSA-N. The full InChI is InChI=1S/C52H73N5O12/c1-27(2)26-56-19-17-52(18-20-56)54-38-35-36-41(58)31(6)46-37(35)47(60)51(11,69-46)65-23-16-34(63-12)30(5)44(66-49(62)57-21-24-64-25-22-57)33(8)45-32(7)43(67-50(9,10)68-45)28(3)14-13-15-29(4)48(61)53-40(42(36)59)39(38)55-52/h13-16,23,27-28,30,32-34,43-45,49,54,58-59,62H,17-22,24-26H2,1-12H3/b14-13+,23-16+,29-15-,53-40-/t28-,30+,32+,33-,34-,43-,44+,45+,49?,51-/m0/s1.
What are the key properties of (7S,9E,11S,12R,13R,14R,15R,19S,20S,21E,23Z,35R)-2,34-dihydroxy-13-[hydroxy(morpholin-4-yl)methoxy]-11-methoxy-3,7,12,14,17,17,20,24,35-nonamethyl-1'-(2-methylpropyl)spiro[8,16,18,36-tetraoxa-26,29,31-triazahexacyclo[25.6.1.14,7.115,19.05,33.028,32]hexatriaconta-1(34),2,4,9,21,23,26,28,32-nonaene-30,4'-piperidine]-6,25-dione?
(7S,9E,11S,12R,13R,14R,15R,19S,20S,21E,23Z,35R)-2,34-dihydroxy-13-[hydroxy(morpholin-4-yl)methoxy]-11-methoxy-3,7,12,14,17,17,20,24,35-nonamethyl-1'-(2-methylpropyl)spiro[8,16,18,36-tetraoxa-26,29,31-triazahexacyclo[25.6.1.14,7.115,19.05,33.028,32]hexatriaconta-1(34),2,4,9,21,23,26,28,32-nonaene-30,4'-piperidine]-6,25-dione has a molecular weight of 960.18 g/mol, XLogP of 5.61, 6 rotatable bonds, 4 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for (7S,9E,11S,12R,13R,14R,15R,19S,20S,21E,23Z,35R)-2,34-dihydroxy-13-[hydroxy(morpholin-4-yl)methoxy]-11-methoxy-3,7,12,14,17,17,20,24,35-nonamethyl-1'-(2-methylpropyl)spiro[8,16,18,36-tetraoxa-26,29,31-triazahexacyclo[25.6.1.14,7.115,19.05,33.028,32]hexatriaconta-1(34),2,4,9,21,23,26,28,32-nonaene-30,4'-piperidine]-6,25-dione is sourced from PubChem (CID 177145158), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).